Lansdowne Partners (UK)’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-19,254
Closed -$1.15M 52
2018
Q1
$1.15M Sell
19,254
-89,183
-82% -$5.95M 0.01% 40
2017
Q4
$8.53M Sell
108,437
-158,987
-59% -$12.8M 0.08% 28
2017
Q3
$22.5M Buy
267,424
+53,281
+25% +$3.78M 0.23% 16
2017
Q2
$14M Sell
214,143
-42,024
-16% -$2.86M 0.12% 21
2017
Q1
$18.6M Buy
256,167
+16,466
+7% +$1.08M 0.16% 18
2016
Q4
$14M Buy
+239,701
New +$12.7M 0.13% 18

Other funds holding ADNT

Lansdowne Partners (UK)'s ADNT Position: Q2 2018 in Review

Lansdowne Partners (UK) sold out of Adient (ADNT) in Q2 2018, closing a stake of 19,254 shares — an estimated $1.15M sold.

Lansdowne Partners (UK) first reported a position in ADNT in Q4 2016 and held it in 6 quarters. The position peaked at $22.5M in Q3 2017. 377 funds tracked by Wall St. Rank hold ADNT as of Q2 2018.

  • Lansdowne Partners (UK) reported no remaining Adient position as of Q2 2018 after selling out during the quarter.
  • Lansdowne Partners (UK) sold 19,254 Adient shares in Q2 2018, an estimated $1.15M.
  • Lansdowne Partners (UK) first reported a position in Adient in Q4 2016 and held it in 6 quarters.
  • Lansdowne Partners (UK)'s Adient position peaked at $22.5M in Q3 2017.
  • 377 funds tracked by Wall St. Rank held Adient as of Q2 2018.

Based on Lansdowne Partners (UK)'s 13F filing for Q2 2018, filed 13 Aug 2018.